Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Telix-EANM

More Like This

PR Newswire associated0

Telix Announces Reorganisation to Deliver on Strategic Priorities

PR Newswire associated0

First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent

PR Newswire associated0

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer

PR Newswire associated0

First Patient Dosed in Italian Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent

PR Newswire associated0

Illuccix® Receives European Approval

PR Newswire associated0

Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS

PR Newswire associated0

Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

PR Newswire associated0

Illuccix® Approved in the United Kingdom